Received May 1, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | 1 | UNK | — |
had an itchy rash on his chest; This non-serious case was reported by a consumer via interactive digital media and described the occurrence of itchy rash in a 80-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis. On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced itchy rash (Verbatim: had an itchy rash on his chest). The outcome of the itchy rash was not reported. It was unknown if the reporter considered the itchy rash to be related to Shingrix. It was unknown if the company considered the itchy rash to be related to Shingrix. Additional Information: GSK Receipt Date: 25-APR-2025 The patient's wife reported this case. The patent (husband) and reporter were scheduled for second Shingrix shot in the next week and he had an itchy rash on his chest for more than a year.